Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.

  title={Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.},
  author={Willem Joost Wiersinga and Andrew Rhodes and Allen C. Cheng and Sharon J. Peacock and Hallie C. Prescott},
Importance The coronavirus disease 2019 (COVID-19) pandemic, due to the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a worldwide sudden and substantial increase in hospitalizations for pneumonia with multiorgan disease. This review discusses current evidence regarding the pathophysiology, transmission, diagnosis, and management of COVID-19. Observations SARS-CoV-2 is spread primarily via respiratory droplets during close face-to-face contact. Infection can be… 

Figures from this paper

Oral Manifestations of Coronavirus Disease 2019 (COVID-19)
The spectrum of clinicopathologic COVID-19-related oral lesions that can be the first and/or the unique manifestation of the disease are described and suggest that the oral mucosa can also be a target organ for SARS-CoV-2.
COVID-2019 fundamentals
A Comprehensive Review of Coronavirus Disease 2019: Epidemiology, Transmission, Risk Factors, and International Responses
A comprehensive update on the epidemiology, presentation, transmission, risk factors, and public health measures associated with COVID-19 is provided and past insights from previous coronavirus epidemics are reviewed to suggest measures to reduce transmission.
Therapeutic potential of inhalable medications to combat coronavirus disease-2019
SARSCoV-2, the virus responsible for COVID-19 infections, is a mutated version of the novel severe acute respiratory syndrome coronavirus (SARS-CoV), which broke out in 2002.
Antibody responses in mild COVID-19 hospital staff
Structure, Transmission, Diagnostic Symptoms, Host and Entry Mechanism of COVID-19: A Review
A review summarizes the comparative analysis of the emergence and pathogenicity of COVID-19, severe acute respiratory syndrome coronavirus (SARS-CoV), and Middle East respiratory Syndrome coronav virus (MERS- coV) and provides details related to an approach to practice therapeutic combinations to fight against this viral outbreak.
Fever, dry cough, and tiredness are the most common symptoms of COVID-19, and an effective vaccine against this disease will be essential to reduce morbidity and mortality.
A Systemic Review of Pathological Findings in COVID-19 and Its Mechanism of Disease
The focus will primarily be upon the systemic pathology in the various organ systems and how the coronavirus has been affected, and the pathophysiology involved herewith after covid infection.
Severe acute respiratory syndrome (SARS) coronavirus-2 infection (COVID-19) in pregnancy – An overview
Dwi Aryani
Both NLR and d-NLR can be used as a biomarker for the risk factor of COVID-19, despite a higher odd ratio of d- NLR compared to NLR.


Coronavirus disease 2019 (COVID-19) pandemic and pregnancy
Virological assessment of hospitalized patients with COVID-2019
Detailed virological analysis of nine cases of coronavirus disease 2019 (COVID-19) provides proof of active replication of the SARS-CoV-2 virus in tissues of the upper respiratory tract.
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
The COVID-19 pandemic represents the greatest global public health crisis of this generation and, potentially, since the pandemic influenza outbreak of 1918 and both the need and capability to produce high-quality evidence even in the middle of a pandemic.
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.
During the epidemic period of COVID-19, clinicians should suspect severe acute respiratory syndrome coronavirus 2 infection as a differential diagnosis to avoid delayed diagnosis or misdiagnosis and lose the chance to treat and prevent further transmission.
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
In this preliminary uncontrolled case series of 5 critically ill patients with COVID-19 and ARDS, administration of convalescent plasma containing neutralizing antibody was followed by improvement in their clinical status, and these observations require evaluation in clinical trials.
Cardiovascular complications in COVID-19
Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome
A surveillance, diagnostic, and management strategy is proposed that balances potential patient risks and healthcare staff exposure with improvement in meaningful clinical outcomes of acute COVID-19 cardiovascular syndrome.
Presymptomatic Transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020
Evidence of presymptomatic transmission of SARS-CoV-2 underscores the critical role social distancing, including avoidance of congregate settings, plays in controlling the COVID-19 pandemic.
Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
  • Li GuoL. Ren Jianwei Wang
  • Biology, Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2020
The humoral response to SARS-CoV-2 can aid in the diagnosis of COVID-19, including subclinical cases, and the detection efficiency by IgM ELISA is higher than that of qPCR after 5.5 days of symptom onset.